Q/C Technologies, Inc.
QCLS- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001321834
No open-market purchases or sales by Q/C Technologies, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.87M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Q/C Technologies, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- 0 vs. Q4 2024
- Shares held
- 197.3K
- +70.5K (+55.6%) vs. Q4 2024
- Total value
- $69.0K
- −$76.8K (−52.7%) vs. Q4 2024
- New holders
- 3
- 4 more added
- Sold out
- 3
- 2 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QCLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $2.87M |
| Q1 2026 | 18 | $2.16M |
| Q4 2025 | 19 | $3.00M |
| Q3 2025 | 12 | $69.8K |
| Q2 2025 | 33 | $65.3K |
| Q1 2025 | 24 | $69.0K |
| Q4 2024 | 25 | $145.8K |
| Q3 2024 | 20 | $60.3K |
| Q2 2024 | 23 | $114.6K |
| Q1 2024 | 20 | $1.38M |
| Q4 2023 | 50 | $1.64M |
| Q3 2023 | 51 | $2.52M |
| Q2 2023 | 48 | $6.51M |
| Q1 2023 | 50 | $6.98M |
| Q4 2022 | 43 | $4.49M |
| Q3 2022 | 43 | $9.94M |
| Q2 2022 | 39 | $10.3M |
| Q1 2022 | 35 | $22.4M |
| Q4 2021 | 41 | $27.1M |
| Q3 2021 | 28 | $41.8M |
| Q2 2021 | 23 | $30.7M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Q/C Technologies, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 102,035 | $35.7K | 0.00% | +38,850+61.5% | Added |
| Geode Capital Management, LLC | 28,051 | $9.82K | 0.00% | +11,480+69.3% | Added |
| Change Path, LLC | 23,001 | $8.05K | 0.00% | +23,001 | New |
| Key Client Fiduciary Advisors, LLC | 20,000 | $7.00K | 0.00% | +20,000 | New |
| Vanguard Group Inc | 13,999 | $4.90K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 5,051 | $1.77K | 0.00% | +965+23.6% | Added |
| BlackRock, Inc. | 3,803 | $1.33K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 387 | $135 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 201 | $72 | 0.00% | +201 | New |
| Wells Fargo & Company | 167 | $58 | 0.00% | 00.0% | Unchanged |
| Bryn Mawr Trust Co | 134 | $47 | 0.00% | 00.0% | Unchanged |
| Sandy Spring Bank | 116 | $41 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 99 | $32 | 0.00% | −284−74.2% | Reduced |
| Legacy Wealth Managment, LLC | 60 | $21 | 0.00% | 00.0% | Unchanged |
| Harbor Investment Advisory, LLC | 34 | $12 | 0.00% | −56−62.2% | Reduced |
| Arvest Investments, Inc. | 34 | $11 | 0.00% | 00.0% | Unchanged |
| ORG Wealth Partners, LLC | 34 | $11 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 22 | $7 | 0.00% | 00.0% | Unchanged |
| St. Johns Investment Management Company, LLC | 14 | $5 | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 5 | $2 | 0.00% | 00.0% | Unchanged |
| Cornerstone Planning Group LLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Sound Income Strategies, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 60 | $0 | 0.00% | +54+900.0% | Added |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −22,874−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −838−100.0% | Sold out |
| Dogwood Wealth Management LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Legacy Investment Solutions, LLC | – | – | – | – | Not filed |